Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
N/A
-34,073 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
N/A
-42 Reduced 0.12%
34,073 $167,000
Q1 2021

May 13, 2021

SELL
N/A
-100 Reduced 0.29%
34,115 $164,000
Q3 2020

Nov 09, 2020

SELL
N/A
-1,000 Reduced 2.84%
34,215 $141,000
Q2 2020

Jul 20, 2020

SELL
N/A
-8,433 Reduced 19.32%
35,215 $90,000
Q1 2020

Apr 30, 2020

BUY
N/A
3,857 Added 9.69%
43,648 $126,000
Q4 2019

Jan 28, 2020

BUY
N/A
3,077 Added 8.38%
39,791 $151,000
Q3 2019

Nov 04, 2019

BUY
N/A
36,714 New
36,714 $188,000
Q2 2019

Jul 29, 2019

SELL
N/A
-33,766 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
N/A
9,213 Added 37.52%
33,766 $240,000
Q4 2018

Feb 01, 2019

BUY
N/A
24,553 New
24,553 $210,000
Q4 2017

Jan 24, 2018

SELL
N/A
-5,202 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
N/A
5,202
5,202 $110,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.